← Open Payments lookup

RICHARD BROOKS: Open Payments

NPI 1457761314 · ABERDEEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,498 in 68 payments from 13 companies in 2025. Trend: 2023 $961 · 2024 $723 · 2025 $1,498

Food & beverage: $1,397Education: $101
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$255
Janssen Pharmaceuticals, Inc12$227
ABBVIE INC.8$177
Alkermes, Inc.7$158
Teva Pharmaceuticals USA, Inc.3$158
E.R. Squibb & Sons, L.L.C.9$157
Supernus Pharmaceuticals, Inc.5$114
Takeda Pharmaceuticals U.S.A., Inc.3$89
Otsuka America Pharmaceutical, Inc.2$59
Bausch Health US, LLC2$33

Products named: INGREZZA, INVEGA SUSTENNA, VRAYLAR, COBENFY, Qelbree, ARISTADA, TRINTELLIX, REXULTI.

Industry payments across WA — which companies pay providers there.